A new publication regarding tesamorelin appeared on July 8, 2026. The paper, titled "Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH): a clinical trial protocol," was published in BMJ Open.
This publication presents a clinical trial protocol. It outlines the planned study design for evaluating tesamorelin used alongside exercise in people with HIV, focusing on physical function outcomes.
As a protocol paper, the publication describes how the trial is designed rather than reporting outcomes or results. No efficacy data, safety findings, or conclusions are included in this type of publication.
The article is indexed under PubMed ID 42419889 and is available through BMJ Open's website. Researchers and clinicians interested in the study design details can access the full protocol through the listed source.
For readers seeking general background on tesamorelin, including its approved uses and mechanism, the compound overview page provides additional context.